Reproductive Center Of Central New Jersey, S Plainfield, NJ – FDA Inspections

Inspection records and compliance data for Reproductive Center Of Central New Jersey in S Plainfield, New Jersey. 8 FDA inspections on record, last inspected September 13, 2024.

Company Profile

This profile covers Reproductive Center Of Central New Jersey based in S Plainfield, New Jersey, United States.

FDA Inspection History

FDA inspections: 8
OAI: 0
VAI: 1
NAI: 6
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected May 15, 2009. Last inspected September 13, 2024.

Most cited issue areas

Eligibility statement--basis of determination1 inspection
Improper release prevention--storage, I.D.1 inspection
Summary--records used to make determination1 inspection

FDA inspections (8)

Date	Result	FDA center(s)	Insp. #
September 13, 2024	Not classified	Biologics	1250702
September 21, 2021	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1152432
June 12, 2018	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1057126
October 31, 2016	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	992903
October 10, 2014	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	899854
June 24, 2013	VAI	Biologics · Human Cellular, Tissue, and Gene Therapies	837531
June 8, 2011	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	728537
May 15, 2009	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	582781

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Medeast Post OP & Surgical

Lineage Logistics, LLC (Kedrion Biopharma)

Bergen Comm Reg Blood Center

Cell Therapies Manufacturing Facility Hackensack University Medical Center

Robert Wood Johnson University Hospital- Blood Services

American National Red Cross (The)

ABO Holdings Inc

The Valley Hospital Microbiology Laboratory

BioLife Plasma Services LP

New Jersey Organ & Tissue Sharing Network, Inc.